| Serial Number | 98097005 |
| Word Mark | SANGUINE |
| Filing Date | Friday, July 21, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 19, 2024 |
| Goods and Services | Research laboratory analysis of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research. Research laboratory services providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research. Compiling data for research purposes in the field of medical science and medical consultancy. Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications. Providing an online searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes. Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes. Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications. Providing information on the subject of scientific research in the field of biochemistry and biotechnology. Scientific laboratory services. Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications. Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research. Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 8, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, November 30, 2009 |
| First Use In Commerce Date | Monday, November 30, 2009 |
| Party Name | Sanguine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
| Party Name | Sanguine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
| Event Date | Event Description |
| Tuesday, July 25, 2023 | NEW APPLICATION ENTERED |
| Monday, August 21, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 25, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 25, 2024 | REMOVED FROM TEAS PLUS |
| Monday, March 25, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, March 25, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, March 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 12, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 2, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 2, 2024 | FINAL REFUSAL WRITTEN |
| Tuesday, July 2, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, August 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 29, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, September 26, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, September 26, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, September 26, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, September 26, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 8, 2024 | RESTORE TO TEAS PLUS |
| Tuesday, October 8, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |